GENEVA, July 1 -- GUANGZHOU UNIRISE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/142125) for “COMPOUND ACTING AS VOLTAGE-GATED SODIUM CHANNEL INHIBITOR AND USE THEREOF”. With publication no. WO/2026/124645, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 405/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....